HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.

10 Clinical Trials
Breast Cancer Clinical Trials Pilot Accepting Patients
nct/study# NA / IOTA-STUDY

Investigating Obstacles To Treatment Adherence For Metastatic Breast Cancer

Learn More
Breast Cancer Clinical Trials NA Accepting Patients
nct/study# NA / 2016-0215

Endocrine Disruptors, Obesity, And Breast Density Among Perimenopausal Women

Learn More
Breast Cancer Clinical Trials Phase III Accepting Patients
nct/study# NCT04109066 / CA209-7FL

A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study Of Nivolumabversus Placebo In Combination With Neoadjuvant Chemotherapy And Adjuvant Endocrine Therapy In Patients With High-Risk, Estrogen Receptor-Positive (ER+), Human Epidermalgrowth Factor Receptor 2-Negative (HER2-) Primary Breast Cancer

Learn More
Breast Cancer Clinical Trials NA Active
nct/study# NA / A191901

Optimizing Endocrine Therapy Through Motivational Interviewing And Text Interventions

Learn More
Breast Cancer Clinical Trials Phase II Active
nct/study# NCT04720664 / OASIS

OASIS: Phase II Trial Of Oral SM-88 In Patients With Metastatic Hormone Receptor-Positive HER2-Negative (HR+/HER2-) Breast Cancer.

Learn More
Breast Cancer Clinical Trials Ib/II Accepting Patients
nct/study# NCT03424005 / CO40115 - Morpheus TNBC

A Phase Ib/Ii,Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Triple-Negative Breast Cancer (Morpheus-Tnbc)

Learn More

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.